Forecast & Rating2 analysts currently cover GRI Bio, of which 2 give a positive rating. The average price target is $18.50, about 843.9% upside from the current price of $1.96. Coverage is limited, so the data is for reference only. Data as of Aug 24, 2026; this does not constitute investment advice.
Aug 24, 2026Price forecast
$18.50843.88%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateJul 27, 2026
Forecast met0.0%
Stock price$1.43
Avg. target$21.0
High target$32
Low target$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.